Avidity Biosciences Inc
Avidity Biosciences Inc logo
RNA

Avidity Biosciences Inc (RNA)

$16.851.4%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$16.8
Day's Range
$18.3108
$10.89
52-Week Range
$29.25
1 month return23.81%
3 month return14.64%
1 year return32.36%
5 year return24.81%

Company Information

Avidity Biosciences, Inc. is driven to change lives with a new class of therapies called Antibody Oligonucleotide Conjugates (AOCs) that are designed to overcome current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Avidity's proprietary AOC platform combines the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. Avidity's lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type 1, and its other muscle programs are focused on the treatment of Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, Pompe disease and muscle atrophy. In addition to its muscle franchise, Avidity has research efforts focused on immune, cardiac and other cell types.
OrganizationAvidity Biosciences Inc
Employees82
CEO
IndustryHealth Technology

Analyst Recommendation

based on 10 analysts ratings

Buy
90%
Buy
10%
Hold
0%
Sell

Based on 10 Wall street analysts offering stock ratings for Avidity Biosciences Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 205.64%

Current

$16.85

Target

$51.5

Recommendation Trend

Based on 10 analyst

Current1M Ago3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
696.3M
Book Value
7.99
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-2.85
PEG Ratio
0.0
Wall Street Target Price
49.8

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
74.66
Price/Book (mrq)
2.09
Enterprise Value
402.3M
Enterprise Value/Revenue
43.13
Enterprise Value/Ebitda
0.0

Technicals

50 Day MA
17.49
200 Day MA
20.61

Institutional Holdings

T. Rowe Price Associates, Inc.

16.19%

RTW INVESTMENTS, LLC

10.04%

FMR Inc

7.91%

BlackRock Inc

6.91%

EcoR1 Capital, LLC

5.78%

Federated Hermes Inc

5.18%

Discover more

Frequently Asked Questions

What is Avidity Biosciences Inc share price today?

Can Indians buy Avidity Biosciences Inc shares?

How can I buy Avidity Biosciences Inc shares from India?

Can Fractional shares of Avidity Biosciences Inc be purchased?

What are the documents required to start investing in Avidity Biosciences Inc stocks?

What are today’s High and Low prices of Avidity Biosciences Inc?

What are today’s traded volumes of Avidity Biosciences Inc?

What is today’s market capitalisation of Avidity Biosciences Inc?

What is the 52 Week High and Low Range of Avidity Biosciences Inc?

How much percentage Avidity Biosciences Inc is down from its 52 Week High?

How much percentage Avidity Biosciences Inc is up from its 52 Week low?

What are the historical returns of Avidity Biosciences Inc?

Who is the Chief Executive Officer (CEO) of Avidity Biosciences Inc?